Saba Capital Amends Filing for Gabelli Healthcare Trust
Ticker: GRX · Form: SC 13D/A · Filed: Aug 9, 2024 · CIK: 1391437
| Field | Detail |
|---|---|
| Company | Gabelli Healthcare & Wellnessrx Trust (GRX) |
| Form Type | SC 13D/A |
| Filed Date | Aug 9, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $17,305,395 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, beneficial-ownership
TL;DR
Saba Capital updated its filing for Gabelli Healthcare. Watch for changes.
AI Summary
Saba Capital Management, L.P. filed an amendment (SC 13D/A) on August 9, 2024, regarding their holdings in Gabelli Healthcare & WellnessRx Trust. The filing indicates a change in their beneficial ownership, though specific new percentage or dollar amounts are not detailed in this excerpt. The filing is an update to a previous submission concerning their stake in the company.
Why It Matters
This filing signals potential shifts in significant shareholder positions within the Gabelli Healthcare & WellnessRx Trust, which could influence the company's stock performance and strategic direction.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings by significant investors like Saba Capital can indicate strategic moves or shifts in confidence, potentially impacting the stock.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filing entity
- Gabelli Healthcare & WellnessRx Trust (company) — Subject company
- Michael D'Angelo (person) — Contact person for Saba Capital
FAQ
What specific changes in beneficial ownership are detailed in this SC 13D/A filing?
This excerpt does not specify the exact percentage or dollar amount of the change in beneficial ownership, only that an amendment (Amendment No. 1) has been filed.
When was this amendment filed with the SEC?
The filing was made on August 9, 2024.
Who is the subject company of this filing?
The subject company is Gabelli Healthcare & WellnessRx Trust.
Who is filing this amendment?
Saba Capital Management, L.P. is filing this amendment.
What is the CUSIP number for the securities involved?
The CUSIP number is 36246K103.
Filing Stats: 1,320 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2024-08-09 07:57:22
Key Financial Figures
- $0.001 — rust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
- $17,305,395 — ported herein. A total of approximately $17,305,395 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 63KB
- 0001062993-24-014730.txt ( ) — 65KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: August 9, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 36246K103 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D on 7/10/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 7/23/2024 Buy 22,571 10.08 7/24/2024 Buy 18,095 10.08 7/25/2024 Buy 36,371 10.19 7/26/2024 Buy 30,734 10.29 7/29/2024 Buy 10,903 10.34 7/30/2024 Buy 24,605 10.42 7/31/2024 Buy 9,560 10.49 8/2/2024 Buy 1,200 10.43 8/7/2024 Buy 20,714 10.22 8/8/2024 Buy 811 10.40